FDA Panel Backs Pfizer COVID Vaccine In Kids Aged 5-11
A U.S. Food and Drug Administration advisory panel voted overwhelmingly Tuesday to approve emergency use of the Pfizer and BioNTech COVID-19 vaccine in children ages 5 to 11, paving the way...To view the full article, register now.
Already a subscriber? Click here to view full article